Autotaxin in Pathophysiology and Pulmonary Fibrosis

Lysophospholipid signaling is emerging as a druggable regulator of pathophysiological responses, and especially fibrosis, exemplified by the relative ongoing clinical trials in idiopathic pulmonary fibrosis (IPF) patients. In this review, we focus on ectonucleotide pyrophosphatase-phosphodiesterase...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninou, Ioanna, Magkrioti, Christiana, Aidinis, Vassilis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008954/
https://www.ncbi.nlm.nih.gov/pubmed/29951481
http://dx.doi.org/10.3389/fmed.2018.00180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008954/
https://www.ncbi.nlm.nih.gov/pubmed/29951481
http://dx.doi.org/10.3389/fmed.2018.00180

Ejemplares similares